Growth hormone

CJC-1295 without DAC

CJC1295 (Without DAC)

The catalogue designation CJC1295 without DAC must be kept separate from the albumin-binding CJC-1295 tested in the original long-acting studies. Removing DAC changes the identity being discussed.

Reviewed September 2026

Residues
Not established. unverified: Identity/chemical-form specification required. The without-DAC designation does not by itself establish a unique sequence and terminal chemistry. The original CJC-1295 paper concerns a DAC-bearing molecule; its numeric properties must not be copied here.
Average mass
Not established. unverified: Identity/chemical-form specification required. The without-DAC designation does not by itself establish a unique sequence and terminal chemistry. The original CJC-1295 paper concerns a DAC-bearing molecule; its numeric properties must not be copied here.
pI
Not established. unverified: Identity/chemical-form specification required. The without-DAC designation does not by itself establish a unique sequence and terminal chemistry. The original CJC-1295 paper concerns a DAC-bearing molecule; its numeric properties must not be copied here.

Reference details

Reference details
ResiduesNot established
Average massNot established
pINot established
Identity
AliasesCJC1295 (Without DAC)
Research areaGrowth hormone

Property basis and sources

These describe the reference compound or formulation, not identification or testing of the supplied lot.

The without-DAC designation does not by itself establish a unique sequence and terminal chemistry. The original CJC-1295 paper concerns a DAC-bearing molecule; its numeric properties must not be copied here.

  • Residues: Not established (unverified). Identity/chemical-form specification required. The without-DAC designation does not by itself establish a unique sequence and terminal chemistry. The original CJC-1295 paper concerns a DAC-bearing molecule; its numeric properties must not be copied here. Residues source 1
  • Average mass: Not established (unverified). Identity/chemical-form specification required. The without-DAC designation does not by itself establish a unique sequence and terminal chemistry. The original CJC-1295 paper concerns a DAC-bearing molecule; its numeric properties must not be copied here. Average mass source 1
  • pI: Not established (unverified). Identity/chemical-form specification required. The without-DAC designation does not by itself establish a unique sequence and terminal chemistry. The original CJC-1295 paper concerns a DAC-bearing molecule; its numeric properties must not be copied here. pI source 1

Reference scope and linked records

Reference type: Peptide designation requiring specification.

This is a research-reference entry, not a product certificate, treatment recommendation or administration guide. The sources below describe their own materials and methods. Catalogue identity, lot testing and clinical evidence are separate questions.

Catalogue context: CJC1295 (Without DAC). The product retains its own name and specification; this link does not certify equivalence to published study material.

Related references

Sources and their scope

  1. hGRF1-29-albumin bioconjugates: identification of CJC-1295. Comparison source only; it does not identify CJC-1295 without DAC.

Source check: 26 September 2026. This is an editorial source check, not a claim of independent clinical or laboratory review.

About CJC-1295 without DAC

Identity and context

The original chemistry paper identifies CJC-1295 using a substituted GRF fragment and a reactive group for albumin conjugation. The current product name explicitly says without DAC but does not supply a verified full structure. This reference therefore does not silently equate it with a particular modified GRF sequence.

Reference classification

Peptide designation requiring specification. The linked catalogue product is CJC1295 (Without DAC). This reference does not independently authenticate the material supplied.

Storage and handling

Analytical specification

Request the exact sequence, substitutions, stereochemistry and terminal chemistry. Confirm absence of the DAC group and do not assign a molecular mass until the delivered identity is defined.

Storage and experimental handling

Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide.

Research evidence

Research evidence for this compound
AreaSummaryEvidence
What the source examinesThe cited paper explains why the conjugation group matters and provides context for the with-DAC compound. It is a comparison source, not direct evidence for the pharmacokinetics or efficacy of the Aminos without-DAC material.Source context
What cannot be inferredPublished long-acting CJC-1295 hormone responses cannot be copied across to a without-DAC listing. Nor does a shared GHRH-related name prove equivalence to sermorelin, tesamorelin or an unspecified blend.Evidence limits

References

Sources used for the data on this page, checked September 2026.

  1. hGRF1-29-albumin bioconjugates: identification of CJC-1295Comparison only; not evidence for this product identity.

Reference information only. This page describes the chemistry and published research context of a laboratory compound. Nothing here is medical or dosing advice. Aminos compounds are for laboratory research use only and are not medicines.